Wision A.I.’s Polyp Detection Software Secures NMPA Approval for Colonoscopy Use

The National Medical Products Administration (NMPA) has approved China-based Wision A.I.’s intestinal polyp electronic colonoscopy image-assisted detection software for marketing in China. The software marks the country’s first deep learning – powered tool designed to aid in polyp detection during endoscopic procedures.

Product Features
The software integrates with specified electronic colonoscopes, enabling real – time display of suspected polyp areas on independent video outputs during adult colonoscopies. Its deep learning algorithms achieve high performance, strong generalization, and robustness even with small sample sizes, making it a valuable addition to colorectal cancer screening workflows.

Clinical Benefits
By highlighting potential polyp regions in real time, the software facilitates earlier detection of precancerous lesions, which is critical for reducing the incidence and mortality of rectal cancer. The product’s advanced capabilities aim to enhance diagnostic accuracy and efficiency in gastrointestinal endoscopy.-Fineline Info & Tech

Insight, China's Pharmaceutical Industry